Abstract:Objective To evaluate the clinical results of treatment for osteosarcoma of the extremities with adjuvant chemotherapy regimen Methods Sixty seven patients with ⅡB extremity osteosarcoma were treated with the combination of adjuvant chemotherapy regimen and definitive surgery Forty seven of them were male and twenty four were female The mean age of the patients at the time of diagnosis was 20 years (ranged 10～51 years) Sixty four lesions involved the lower extremity, with 45 involving the distal femur, 14 the upper tibia, 3 the upper fibula and 2 the proximal femur; Three involved the upper end of the humerus The study of subtype of osteosarcoma revealed that 51 were osteoblastic, 6 chondroblastic, 5 fibroblastic and 5 the other subtypes The patients were divided into three groups according to the adjuvant chemotherapy regimen given, the first group consisted of 23 cases, who were treated with the combination of the presurgical cisplatin hyperthermic isolated limb perfusion (CDP-HILP) and postoperative chemotherapy; the second group of 20 cases, who were treated with the combination of the presurgical CBP-HILP and postoperative chemotherapy; and the other 24 cases were treated with postoperative chemotherapy alone Twenty nine of the 67 patients treated surgically had limb salvage procedures; 35 had amputations and 3 had Tikhoff-Limbergs surgery Multiple histologic sections were procured and examined from each of the surgical specimens in the patients who were treated with preoperative HILP to determine the effect of chemotherapy All patients were followed from 3 to 9 years, and the data were statistically analeyed using SPSS 7 0 Results Among 67 cases, 41 (61 19%) had relapse free survival(RFS) in 2 years after surgery, 37 (55 22%) had RFS in 3 years after surgery, and RFS probability at 5 years after surgery was 49 56% Log-rank analysis showed no significant difference in RFS probability among the three groups(P=0 517 1), but there was a significant difference in RFS probability between patients who had limb salvage procedure and those had amputation(P=0 009 7) Age, sex, site and subtype were not significant prognostic variables in this group of patients Correction analysis revealed that the RFS probability were not related with the rate of the tumor necrosis (P=0 058) Conclusion The data revealed that 1) The chemotherapy regimen mainly including platinic drugs was effective treatment for osteosarcoma ,and was more simple and less expensive than any previous reported chemotherapy for steosarcoma, 2) CDP of chemotherapy regimen for osteosarcoma, which had more nephritic and audio toxicity could be replaced by CBP , And 3)Whether the preoperative chemotherapy is suitable for the patients in whom amputation is inevitable (based on age ,size, and involvement of local structure) remains unclear

Clinical Analysis on Efficacy and Prognosis of New Adjuvant Chemotherapy for Stageiib Osteosarcoma

Clinical Study on the New Adjuvant Chemotherapy for the Treatment of Osteosarcoma

The assessment of the effectiveness of the adjuvant chemotherapy regimen for the treatment of osteosarcoma

The Treatment of Stage III Osteosarcoma

The diuleal features and prognostic factors of osteosarcoma in adult

Analysis of prognostic factors of stage ⅡB osteosarcoma in extremities

[Evaluation of Neoadjuvant Chemotherapy for Patients with Stage II Osteosarcoma].

Survival Benefit of Adjuvant Chemotherapy for Patients with Poorly Differentiated Stage IIA Colon Cancer

Analysis of Prognostic Factors in 333 Chinese Patients with High-Grade Osteosarcoma Treated by Multidisciplinary Combined Therapy.

Research on tumor necrosis rate in evaluating preoperative chemotherapy of osteosarcoma

Clinical analysis of Chinese limb osteosarcoma patients treated by two combinations of methotrexate, cisplatin, doxorubicin and ifosfamide.

Pirarubicin Versus Doxorubicin in Neoadjuvant/adjuvant Chemotherapy for Stage IIB Limb High-Grade Osteosarcoma: Does the Analog Matter?

Analysis of prognostic factors for osteosarcoma of the flat bone and irregular bone

Neoadjuvant chemotherapy combined with limb salvage surgery for treatment of osteosarcoma long - term survival analysis

Radiographic response to neoadjuvant therapy and its impact on scope of surgery and prognosis in stage IIB/III soft tissue sarcomas

Three Hematological Indexes That May Serve As Prognostic Indicators in Patients with Primary, High-Grade, Appendicular Osteosarcoma

[Prognostic Factors for 72 Patients with Osteosarcoma of the Extremity Treated with Neoadjuvant Chemotherapy].

Clinical effects of deoxyribonucleotide natrium on leukocytopenia after new adjuvant chemotherapy for osteosarcoma

COX Proportional-Hazard Regression Analysis of Prognostic Factors in 52 Adult Patients with Osteosarcoma

Retrospective Analysis of Clinical Differences between Preadolescent and Young Adult Patients with Osteosarcoma and Their Prognostic Factors

Doxorubicin Loaded Nano-Gel Preoperative Application Effect as Adjuvant Chemotherapy on Osteosarcoma